40 C.F.R. § 82.17
Apportionment of baseline production allowances for class II controlled substances
The following persons are apportioned baseline production allowances for HCFC-22, HCFC-141b, HCFC-142b, HCFC-123, HCFC-124, HCFC-225ca, and HCFC-225cb as set forth in the following table:
| Person | Controlled substance | Allowances (kg) |
|---|---|---|
| AGC Chemicals Americas | HCFC-225ca | 266,608 |
| HCFC-225cb | 373,952 | |
| Arkema | HCFC-22 | 46,692,336 |
| HCFC-141b | 24,647,925 | |
| HCFC-142b | 484,369 | |
| DuPont | HCFC-22 | 42,638,049 |
| HCFC-124 | 2,269,210 | |
| Honeywell | HCFC-22 | 37,378,252 |
| HCFC-141b | 28,705,200 | |
| HCFC-142b | 2,417,534 | |
| HCFC-124 | 1,759,681 | |
| MDA Manufacturing | HCFC-22 | 2,383,835 |
| Solvay Specialty Polymers USA, LLC | HCFC-142b | 6,541,764 |
Notes of Decisions
Cited in 1
case, 2010–2010 · leading case: Arkema Inc. v. Env't Prot. Agency, 618 F.3d 1 (D.C. Cir. 2010).
Arkema Inc. v. Env't Prot. Agency, 618 F.3d 1 (D.C. Cir. 2010). “The Proposed Rule stated the EPA was proposing to apportion company-specific baselines in amounts equivalent to the existing baselines published in the 2003 Rule, see 40 C.F.R. §§ 82.17 (2003) (apportionment of baseline production allowances), 82.”
Annotations are extracted automatically from the opinions in the
Syfert caselaw corpus and ranked by authority, recency, and
treatment. Dots show Syfertize treatment of the citing case itself.